Show an ad over header. AMP

I am the FIRST!!!

Private equity bets on delayed tax reform in Biden administration

In normal times, private equity would be nervous about Democratic Party control of both the White House and Congress. But in pandemic-consumed 2021, the industry seems sanguine.

Driving the news: Industry executives and lobbyists paid very close attention to Treasury Secretary nominee Janet Yellen's confirmation hearings this week, and came away convinced that tax reform isn't on the near-term agenda.


The history: President Biden campaigned on a tax policy plan that was significantly worse for private equity than was Trump's.

  • He pledged to raise income tax rates on top earners, eliminate the preferential tax treatment of capital gains and increase corporate taxes (including a new minimum tax on book income).

The reality: Yellen, as expected, endorsed Biden's tax plan in her testimony. But she also said the administration's top legislative priority would be economic stimulus, with infrastructure not too far behind.

  • Both of those would be major boons to private equity, as would be greater predictability on trade policy.

The bet: Private equity is keeping its fingers crossed that tax reform gets pushed off for at least a year, at which point election politics might interfere. And then, in the industry's best-case scenario, Republicans then regain control of at least one house of Congress.

The counterargument is that election season might embolden Democrats to raise taxes on the wealthiest Americans, particularly after its stimulus spending spree.

  • There also are some concerns about Gary Gensler as SEC chair. Like Jay Clayton, he knows where some private equity bodies are buried. Unlike Jay Clayton, he might be eager to dig them up.

The bottom line: Private equity is a long-term asset class. But for now it's banking on the short-term.

regular 4 post ff

infinite scroll 4 pff

COVID-19 cases surge across U.S. due to Delta variant

As vaccination rates dwindle and the Delta variant becomes a growing public health concern, COVID cases appear to be surging across the U.S.

The big picture: "Twenty-four states have seen an uptick of at least 10% in Covid-19 cases over the past week," CNN writes. The Centers for Disease Control and Prevention says between June 20 and July 3, the Delta variant accounted for more than 51% of all news cases.

Keep reading...Show less

The drug pricing lawsuit that could blow up Medicare

A federal judge will soon determine whether Pfizer can pay Medicare patients' out-of-pocket expenses for one of its heart medications that is priced at $225,000 per year.

Why it matters: A ruling in Pfizer's favor would legalize something that is viewed as a kickback under current law, and would jeopardize taxpayer coffers by spurring a "gold rush" of pharmaceutical companies to cover Medicare copays for expensive drugs.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;